<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39319956</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-9946</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Revista do Instituto de Medicina Tropical de Sao Paulo</Title><ISOAbbreviation>Rev Inst Med Trop Sao Paulo</ISOAbbreviation></Journal><ArticleTitle>Evaluation of d-dimer as outcome biomarker in COVID-19 acute respiratory distress patients.</ArticleTitle><Pagination><StartPage>e57</StartPage><MedlinePgn>e57</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e57</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1678-9946202466057</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0036-46652024000100228</ELocationID><Abstract><AbstractText>Acute respiratory distress syndrome is a significant complication in critical care patients. COVID-19 (C19)-associated severe respiratory failure is related to it, and d-dimer rise predicts a worse outcome. To investigate the association between d-dimer and the severity of this respiratory syndrome, we conducted a study in C19 intubated patients. A retrospective, single-center observational study was conducted with 64 C19 adult intubated patients. Strata of d-dimer results between patients was evaluated using survival analysis. Survival was higher in mild respiratory distress patients. D-dimer showed poor sensitivity and specificity in predicting respiratory failure severity. Risk assessment for death showed a higher prevalence of admission d-dimer results (HR 1.335; 95% CI 0.695-2.564). Our sample confidently represented the medical profile of C19 severe patients. Sepsis development in C19 is associated with the inflammatory storm in respiratory distress syndrome. As the receiver operating curves show, the increase in d-dimer results is consistent with inflammation rather than a prognostic biomarker. As expected, severe respiratory distress patients presented higher mortality. In summary, d-dimer results are not associated with the prognosis of C19 respiratory distress syndrome patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diniz</LastName><ForeName>Simone Magalhães</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-0429-7182</Identifier><AffiliationInfo><Affiliation>Centro Universitario Faculdade de Medicina ABC, Departamento de Medicina Interna, Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauad</LastName><ForeName>Vitor Augusto Queiroz</ForeName><Initials>VAQ</Initials><Identifier Source="ORCID">0000-0003-4727-7464</Identifier><AffiliationInfo><Affiliation>Centro Universitario Faculdade de Medicina ABC, Departamento de Hematologia, Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Caio Cesar Ferreira</ForeName><Initials>CCF</Initials><Identifier Source="ORCID">0009-0005-8607-6683</Identifier><AffiliationInfo><Affiliation>Centro Universitario Faculdade de Medicina ABC, Departamento de Cardiologia,Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Estadual Mário Covas, Unidade de Terapia Intensiva, Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacci</LastName><ForeName>Marcelo Rodrigues</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0001-8578-8404</Identifier><AffiliationInfo><Affiliation>Centro Universitario Faculdade de Medicina ABC, Departamento de Medicina Interna, Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Estadual Mário Covas, Unidade de Terapia Intensiva, Santo André, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Inst Med Trop Sao Paulo</MedlineTA><NlmUniqueID>7507484</NlmUniqueID><ISSNLinking>0036-4665</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="Y">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>CONFLICT OF INTERESTS:</b> The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>8</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319956</ArticleId><ArticleId IdType="pmc">PMC11421419</ArticleId><ArticleId IdType="doi">10.1590/S1678-9946202466057</ArticleId><ArticleId IdType="pii">S0036-46652024000100228</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gorman EA, O'Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet. 2022;400:1157–1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">36070788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213:54–6.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361309</ArticleId><ArticleId IdType="pubmed">32572965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VC, Edwards KM, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2022:ciac724</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Auditeau C, Khider L, Planquette B, Sanchez O, Smadja DM, Gendron N. D-dimer testing in clinical practice in the era of COVID-19. Res Pract Thromb Haemost. 2022;6:e12730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9133433</ArticleId><ArticleId IdType="pubmed">35664536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chocron R, Duceau B, Gendron N, Ezzouhairi N, Khider L, Trimaille A, et al. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: insights from a French multicenter cohort study. Arch Cardiovasc Dis. 2021;114:381–393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7942155</ArticleId><ArticleId IdType="pubmed">33846096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch H, Linde-Zwirble WT, Harrison DA, Barnato AE, Rowan KM, Angus DC. Use of intensive care services during terminal hospitalizations in England and the United States. Am J Respir Crit Care Med. 2009;180:875–880.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazra A, Gogtay N. Biostatistics series module 3: comparing groups: numerical variables. Indian J Dermatol. 2016;61:251–260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4885176</ArticleId><ArticleId IdType="pubmed">27293244</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes: a systematic review and meta-analysis. PLoS One. 2021;16:e0246318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877631</ArticleId><ArticleId IdType="pubmed">33571301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ZJ, Subramaniam A, Ponnapa Reddy M, Blecher G, Kadam U, Afroz A, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation: a meta-analysis. Am J Respir Crit Care Med. 2021;203:54–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781141</ArticleId><ArticleId IdType="pubmed">33119402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A, De Vito A, Scano V, Paliogiannis P, Fiore V, Madeddu G, et al. The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients. J Infect Dev Ctries. 2021;15:353–359.</Citation><ArticleIdList><ArticleId IdType="pubmed">33839709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartini S, Massobrio L, Cutuli O, Campodonico P, Bernini C, Sartini M, et al. Role of SatO2, PaO2/FiO2 ratio and PaO2 to predict adverse outcome in COVID-19: a retrospective, cohort study. 11534Int J Environ Res Public Health. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582831</ArticleId><ArticleId IdType="pubmed">34770046</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364371</ArticleId><ArticleId IdType="pubmed">32667669</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic value of d-dimer in COVID-19: a meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021;27:10760296211010976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114749</ArticleId><ArticleId IdType="pubmed">33926262</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth K, Fresilli S, Paoli N, Maiucci G, Salvioni M, Kotani Y, et al. D-dimer levels in non-COVID-19 ARDS and COVID-19 ARDS patients: a systematic review with meta-analysis. PLoS One. 2023;18:e0277000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9901787</ArticleId><ArticleId IdType="pubmed">36745595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes LA, Agrawal DK. Thromboembolism in the complications of long COVID-19. Cardiol Cardiovasc Med. 2023;7:123–128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310316</ArticleId><ArticleId IdType="pubmed">37389402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragnoli B, Da Re B, Galantino A, Kette S, Salotti A, Malerba M. Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence. 8945Int J Mol Sci. 2023;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219009</ArticleId><ArticleId IdType="pubmed">37240292</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>